Zanaflex
Product Images NDC 21695-373

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zanaflex (NDC 21695-373). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (B581d63f 61cb 41b6 A7ca 24bd0b32a8ae 01)

Chemical structure diagram showing the molecular structure of the active ingredient in Zanaflex, including chlorine (Cl), nitrogen (N), sulfur (S), and hydrogen chloride (HCl) components as part of the molecule.*

FDA Label Image

Graph 1 (B581d63f 61cb 41b6 A7ca 24bd0b32a8ae 02)

A line graph showing plasma tizanidine concentration (ng/mL) over 24 hours after dosing. It compares the concentration-time profiles for 4 mg tizanidine tablets and capsules taken with and without food. The y-axis represents plasma concentration, and the x-axis shows hours from dosing. The graph features four curves corresponding to each condition.*

FDA Label Image

Graph 2 (B581d63f 61cb 41b6 A7ca 24bd0b32a8ae 03)

A line graph showing improvement in Ashworth Score over six hours post-dose for three groups: 16 mg tizanidine, 8 mg tizanidine, and placebo. The vertical axis measures improvement in score, the horizontal axis shows hours post-dose, with data points and error bars for each group.*

FDA Label Image

Graph 3 (B581d63f 61cb 41b6 A7ca 24bd0b32a8ae 04)

A clinical study plot showing improvement in Ashworth Score with tizanidine (mean dose 28.8 mg) versus placebo over three time points: End of Titration (Study Week 3), End of Maintenance (Study Week 7), and Endpoint (Last Observation Carried Forward). Tizanidine groups show greater improvement (negative scores) compared to placebo at all time points with error bars included.*

FDA Label Image

Zanaflex 4mg (B581d63f 61cb 41b6 A7ca 24bd0b32a8ae 05)

Zanaflex 4mg capsules packaging label showing 30 capsules. Each capsule contains 4.58mg Tizanidine Hydrochloride equivalent to 4mg tizanidine base. The label includes product ID PZ037330 and specifies prescription use only. It is labeled by Physician Partner, a division of Rebel Distributors Corp.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.